DrugLib.com — Drug Information Portal

Rx drug information, pharmaceutical research, clinical trials, news, and more

Prednisone (Prednisone) - Nausea - Suspected Cause - Side Effect Reports

 
 



Index of reports > Cases with Nausea (89)

Below is the selection of side effect reports (a.k.a. adverse event reports) related to Prednisone where reactions include nausea. The selected reports were submitted to the FDA during the sample period of about a year.

 Reports 1 - 30 of 89   Next >>

Possible Prednisone side effects in female

Reported by a physician from Sweden on 2012-08-20

Patient: female

Reactions: Nausea, Progressive Multifocal Leukoencephalopathy, Hepatic Enzyme Increased

Adverse event resulted in: death

Drug(s) suspected as cause:
Azathioprine
    Dosage: 150 mg/day
    Administration route: Oral
    Indication: Polymyositis

Cyclophosphamide
    Dosage: 100 mg/day
    Administration route: Oral
    Indication: Polymyositis

Methotrexate
    Dosage: 20 mg/week
    Indication: Polymyositis

Methylprednisolone

Prednisone
    Dosage: 10mg daily

Prednisone
    Dosage: 17.5 mg/day
    Administration route: Oral

Prednisone
    Dosage: 60 mg/day

Prednisone
    Dosage: 2.5 mg/day

Prednisone
    Dosage: 40 mg/day
    Indication: Polymyositis



Possible Prednisone side effects in female

Reported by a physician from Sweden on 2012-08-20

Patient: female

Reactions: Nausea, Progressive Multifocal Leukoencephalopathy, Hepatic Enzyme Increased

Adverse event resulted in: death

Drug(s) suspected as cause:
Azathioprine
    Dosage: 150 mg/day
    Administration route: Oral
    Indication: Polymyositis

Cyclophosphamide
    Dosage: 100 mg/day
    Administration route: Oral
    Indication: Polymyositis

Methotrexate
    Dosage: 20 mg/week
    Indication: Polymyositis

Methylprednisolone

Prednisone
    Dosage: 40 mg/day
    Indication: Polymyositis

Prednisone
    Dosage: 10mg daily

Prednisone
    Dosage: 17.5 mg/day
    Administration route: Oral

Prednisone
    Dosage: 60 mg/day

Prednisone
    Dosage: 2.5 mg/day



Possible Prednisone side effects in female

Reported by a physician from Sweden on 2012-08-20

Patient: female

Reactions: Nausea, Progressive Multifocal Leukoencephalopathy, Hepatic Enzyme Increased

Adverse event resulted in: death

Drug(s) suspected as cause:
Azathioprine
    Dosage: 150 mg/day
    Administration route: Oral
    Indication: Polymyositis

Cyclophosphamide
    Dosage: 100 mg/day
    Administration route: Oral
    Indication: Polymyositis

Methotrexate
    Dosage: 20 mg/week
    Indication: Polymyositis

Methylprednisolone

Prednisone
    Dosage: 40 mg/day
    Indication: Polymyositis

Prednisone
    Dosage: 2.5 mg/day

Prednisone
    Dosage: 10mg daily

Prednisone
    Dosage: 60 mg/day

Prednisone
    Dosage: 17.5 mg/day
    Administration route: Oral



Possible Prednisone side effects in 74 year old male

Reported by a physician from United States on 2012-08-03

Patient: 74 year old male, weighing 89.7 kg (197.3 pounds)

Reactions: Dyspnoea, Fatigue, Syncope, Nausea, Diarrhoea, Wheezing, Hypoxia, Neutrophil Count Decreased

Adverse event resulted in: hospitalization

Drug(s) suspected as cause:
Amoxicillin
    Start date: 2012-05-04

Amoxicillin
    Dosage: patinet took every 4 hours by mistake

Bevacizumab
    Dosage: dose/frequency- 15 mg/kg over 30-90 min on day 1 of a cycle
    Indication: Prostate Cancer
    Start date: 2010-07-27

Docetaxel

Docetaxel
    Dosage: frequency- 75 mg/m2 over 60 min on day 1 of a cycledocetaxel was held for cumulative toxicities
    Indication: Prostate Cancer
    Start date: 2010-07-27

Lenalidomide
    Administration route: Oral
    Indication: Prostate Cancer
    Start date: 2010-07-27

Prednisone
    Administration route: Oral
    Indication: Prostate Cancer
    Start date: 2010-07-27



Possible Prednisone side effects in female

Reported by a physician from Poland on 2012-08-02

Patient: female, weighing 58.0 kg (127.6 pounds)

Reactions: Retroperitoneal Mass, Vomiting, Nausea, Anaemia, Nephropathy Toxic, Folate Deficiency, Iron Deficiency, Herpes Zoster, Vitamin B12 Increased, Asthenia, Beta 2 Microglobulin Increased, Leukopenia

Drug(s) suspected as cause:
Cyclophosphamide
    Indication: Lymphoma
    Start date: 2011-06-22
    End date: 2011-10-27

Doxorubicin Hydrochloride
    Indication: Lymphoma
    Start date: 2011-06-22
    End date: 2011-10-27

Prednisone
    Administration route: Oral
    Indication: Lymphoma
    Start date: 2011-06-22
    End date: 2011-10-27

Rituximab
    Indication: Diffuse Large B-Cell Lymphoma
    Start date: 2011-06-22
    End date: 2011-10-27

Vincristine
    Indication: Lymphoma
    Start date: 2011-06-22
    End date: 2011-10-27

Other drugs received by patient: Heviran; Tamoxifen Citrate



Possible Prednisone side effects in

Reported by a physician from United States on 2012-08-01

Patient:

Reactions: Nausea, Motor Dysfunction, Pain, Rash, Peripheral Sensory Neuropathy, Fatigue, Dyspepsia, Blood Potassium Decreased, Diarrhoea, Neutropenia, Thrombocytopenia

Drug(s) suspected as cause:
Cyclophosphamide
    Dosage: on day 1
    Indication: Waldenstrom's Macroglobulinaemia

Cyclophosphamide
    Dosage: on day 1
    Indication: B-Cell Lymphoma

Cyclophosphamide
    Dosage: on day 1
    Indication: Lymphoma

Cyclophosphamide
    Dosage: on day 1
    Indication: non-Hodgkin's Lymphoma

Cyclophosphamide
    Dosage: on day 1
    Indication: Lymphocytic Lymphoma

Cyclophosphamide
    Dosage: on day 1

Doxorubicin Hydrochloride
    Dosage: on day 1
    Indication: Waldenstrom's Macroglobulinaemia

Doxorubicin Hydrochloride
    Dosage: on day 1
    Indication: Lymphoma

Doxorubicin Hydrochloride
    Dosage: on day 1
    Indication: non-Hodgkin's Lymphoma

Doxorubicin Hydrochloride
    Dosage: on day 1
    Indication: Lymphocytic Lymphoma

Doxorubicin Hydrochloride
    Dosage: on day 1

Doxorubicin Hydrochloride
    Dosage: on day 1
    Indication: B-Cell Lymphoma

Prednisone
    Dosage: on days 1-5
    Administration route: Oral
    Indication: Lymphoma

Prednisone
    Dosage: on days 1-5
    Administration route: Oral
    Indication: B-Cell Lymphoma

Prednisone
    Dosage: on days 1-5
    Administration route: Oral
    Indication: Waldenstrom's Macroglobulinaemia

Prednisone
    Dosage: on days 1-5
    Administration route: Oral
    Indication: Lymphocytic Lymphoma

Prednisone
    Dosage: on days 1-5
    Administration route: Oral

Prednisone
    Dosage: on days 1-5
    Administration route: Oral
    Indication: non-Hodgkin's Lymphoma

Rituximab
    Dosage: maintenance
    Indication: Waldenstrom's Macroglobulinaemia

Rituximab
    Dosage: maintenance

Rituximab
    Dosage: on day 1
    Indication: Lymphocytic Lymphoma

Rituximab
    Dosage: maintenance

Rituximab
    Dosage: on day 1

Rituximab
    Dosage: on day 1
    Indication: B-Cell Lymphoma

Rituximab
    Dosage: on day 1
    Indication: non-Hodgkin's Lymphoma

Rituximab
    Dosage: maintenance

Rituximab
    Dosage: maintenance

Rituximab
    Dosage: on day 1
    Indication: Lymphoma

Rituximab
    Dosage: maintenance

Rituximab
    Dosage: on day 1

Velcade
    Dosage: for every 6 months for 2 years or till progressive disease (maintenance)

Velcade
    Dosage: 1.0 to 1.6 mg/m2 on days 1 and 8

Velcade
    Dosage: for every 6 months for 2 years or till progressive disease (maintenance)
    Indication: non-Hodgkin's Lymphoma

Velcade
    Dosage: 1.0 to 1.6 mg/m2 on days 1 and 8
    Indication: B-Cell Lymphoma

Velcade
    Dosage: 1.0 to 1.6 mg/m2 on days 1 and 8

Velcade
    Dosage: 1.0 to 1.6 mg/m2 on days 1 and 8
    Indication: Lymphoma

Velcade
    Dosage: for every 6 months for 2 years or till progressive disease (maintenance)
    Indication: Lymphocytic Lymphoma

Velcade
    Dosage: for every 6 months for 2 years or till progressive disease (maintenance)

Velcade
    Dosage: for every 6 months for 2 years or till progressive disease (maintenance)

Velcade
    Dosage: for every 6 months for 2 years or till progressive disease (maintenance)

Velcade
    Dosage: 1.0 to 1.6 mg/m2 on days 1 and 8
    Indication: Waldenstrom's Macroglobulinaemia

Velcade
    Dosage: 1.0 to 1.6 mg/m2 on days 1 and 8

Vincristine
    Dosage: on day 1 not to exceed 1.5 mg from level 1 and 2 and not to exceed 2 mg for level 3
    Indication: Waldenstrom's Macroglobulinaemia

Vincristine
    Dosage: on day 1 not to exceed 1.5 mg from level 1 and 2 and not to exceed 2 mg for level 3
    Indication: Lymphocytic Lymphoma

Vincristine
    Dosage: on day 1 not to exceed 1.5 mg from level 1 and 2 and not to exceed 2 mg for level 3

Vincristine
    Dosage: on day 1 not to exceed 1.5 mg from level 1 and 2 and not to exceed 2 mg for level 3
    Indication: B-Cell Lymphoma

Vincristine
    Dosage: on day 1 not to exceed 1.5 mg from level 1 and 2 and not to exceed 2 mg for level 3
    Indication: non-Hodgkin's Lymphoma

Vincristine
    Dosage: on day 1 not to exceed 1.5 mg from level 1 and 2 and not to exceed 2 mg for level 3
    Indication: Lymphoma

Other drugs received by patient: Diphenhydramine HCL; Acetaminophen; Ondansetron



Possible Prednisone side effects in male

Reported by a consumer/non-health professional from Brazil on 2012-07-31

Patient: male

Reactions: Abdominal Discomfort, Gastrointestinal Motility Disorder, Nausea, Dyspepsia, Memory Impairment, Depression, Gastrointestinal Injury

Drug(s) suspected as cause:
Cyclosporine
    Dosage: unk ukn, unk

Myfortic

Prednisone
    Dosage: unk ukn, unk



Possible Prednisone side effects in male

Reported by a consumer/non-health professional from Brazil on 2012-07-31

Patient: male

Reactions: Abdominal Discomfort, Gastrointestinal Motility Disorder, Nausea, Dyspepsia, Memory Impairment, Depression, Gastrointestinal Injury

Drug(s) suspected as cause:
Cyclosporine
    Dosage: unk ukn, unk

Myfortic

Prednisone
    Dosage: unk ukn, unk



Possible Prednisone side effects in female

Reported by a consumer/non-health professional from United States on 2012-07-30

Patient: female, weighing 79.4 kg (174.6 pounds)

Reactions: Back Pain, Contusion, Spinal Pain, Nausea, Pain in Extremity, Headache, Gastric Disorder, Somnolence, Fall, Erythema, Rheumatoid Arthritis, Fatigue, Diarrhoea, Impaired Healing, Oedema Peripheral, Spinal Disorder, Infusion Related Reaction

Drug(s) suspected as cause:
Prednisone
    Administration route: Oral
    Indication: Rheumatoid Arthritis
    End date: 2012-01-01

Prednisone
    Administration route: Oral
    Start date: 2012-01-01

Remicade
    Start date: 2012-05-25

Remicade
    Indication: Rheumatoid Arthritis
    Start date: 2012-07-06

Remicade
    Start date: 2012-01-01

Other drugs received by patient: Albuterol Sulphate; Omega 3-6-9; Aspirin; Flonase; Lyrica; Levothyroxine Sodium; Tramadol Hydrochloride; Levothyroxine Sodium; Hydrochlorothiazide; Lidoderm; Lutein; Omeprazole; Flonase; Vitamin B Complex CAP; Albuterol Sulphate; Multi-Vitamins; Cyclobenazprine; Hydrocodone Bitartrate



Possible Prednisone side effects in 51 year old male

Reported by a physician from Germany on 2012-07-27

Patient: 51 year old male, weighing 113.0 kg (248.6 pounds)

Reactions: Nausea, Hypotension, Gastritis, Leukopenia

Adverse event resulted in: hospitalization

Drug(s) suspected as cause:
Cabazitaxel
    Start date: 2012-03-29
    End date: 2012-03-29

Cabazitaxel
    Start date: 2012-01-19
    End date: 2012-01-19

Prednisone
    Administration route: Oral
    Start date: 2012-01-19
    End date: 2012-04-04

Other drugs received by patient: Pantoprazole; Luteinizing Hormone-Releasing Hormone; Amiodarone HCL; Enoxaparin Sodium; Bisoprolol Fumarate; Pravastatin; Simvastatin



Possible Prednisone side effects in female

Reported by a physician from Germany on 2012-07-27

Patient: female

Reactions: Vomiting, Nausea, Hyponatraemia

Adverse event resulted in: hospitalization

Drug(s) suspected as cause:
Cyclophosphamide
    Dosage: 1027.5 mg, unk
    Indication: B-Cell Lymphoma
    Start date: 2012-07-04
    End date: 2012-07-04

Doxorubicin Hydrochloride
    Dosage: 66.5 mg, qd
    Indication: B-Cell Lymphoma
    Start date: 2012-07-04
    End date: 2012-07-04

Pegfilgrastim
    Dosage: 6 mg, unk
    Indication: B-Cell Lymphoma
    Start date: 2012-07-08
    End date: 2012-07-08

Prednisone
    Dosage: 100 mg, unk
    Administration route: Oral
    Indication: B-Cell Lymphoma
    Start date: 2012-07-03
    End date: 2012-07-08

Rituximab
    Dosage: 513.75 mg, qd
    Indication: B-Cell Lymphoma
    Start date: 2012-07-04
    End date: 2012-07-04

Vincristine
    Dosage: 2.76 mg, unk
    Indication: B-Cell Lymphoma
    Start date: 2012-07-04
    End date: 2012-07-04

Other drugs received by patient: Allopurinol; Amlodipine Besylate; Losartan Potassium; Pantoprazole Sodium; Metoclopramide; Bisoprolol Fumarate



Possible Prednisone side effects in male

Reported by a physician from Brazil on 2012-07-26

Patient: male

Reactions: Nausea, Aspartate Aminotransferase Increased, Alanine Aminotransferase Increased

Drug(s) suspected as cause:
Acetaminophen
    Dosage: unk
    Indication: Headache
    Start date: 2010-12-13

Acyclovir
    Dosage: 4000 unk, unk
    Indication: Herpes Zoster
    Start date: 2010-12-18
    End date: 2010-12-25

Azithromycin
    Dosage: 1500 unk, unk
    Indication: Prophylaxis
    Start date: 2010-11-04

Bactrim
    Dosage: 400 mg, unk
    Indication: Prophylaxis
    Start date: 2010-12-13

Efavirenz
    Dosage: unk
    Indication: HIV Infection
    Start date: 2010-11-25
    End date: 2011-01-01

Efavirenz
    Dosage: unk

Ethambutol Hydrochloride
    Dosage: unk
    Indication: Tuberculosis
    Start date: 2010-10-16
    End date: 2010-12-27

Ethambutol Hydrochloride
    Dosage: unk

Isoniazid
    Dosage: unk
    Indication: Tuberculosis
    Start date: 2010-10-16
    End date: 2011-01-01

Lamivudine
    Dosage: 300 mg, qd
    Indication: HIV Infection
    Start date: 2010-11-25

Prednisone
    Dosage: 40 mg, unk
    Indication: Meningitis
    Start date: 2010-10-16

Pyrazinamide
    Dosage: 1200 mg, unk
    Indication: Tuberculosis
    Start date: 2010-10-16
    End date: 2010-12-27

Rifampin
    Dosage: 450 mg, qd
    Indication: Tuberculosis
    Start date: 2010-10-16
    End date: 2011-01-01

Rifampin
    Dosage: 450 mg, qd

Tenofovir Disoproxil Fumarate
    Indication: HIV Infection



Possible Prednisone side effects in male

Reported by a physician from Poland on 2012-07-26

Patient: male, weighing 72.0 kg (158.4 pounds)

Reactions: Neurotoxicity, Abdominal Pain, Basal Cell Carcinoma, Squamous Cell Carcinoma, Nausea, Toxicity To Various Agents, Blood Creatinine Increased

Drug(s) suspected as cause:
Azathioprine
    Dosage: 50 mg a day
    Administration route: Oral
    Indication: Immunosuppression
    Start date: 2000-12-15
    End date: 2007-01-18

Myfortic
    Dosage: 1080 mg per day
    Indication: Immunosuppression
    Start date: 2007-02-02
    End date: 2009-03-12

Myfortic
    Dosage: 360 mg, tid
    Administration route: Oral
    Start date: 2011-11-17
    End date: 2011-12-14

Myfortic
    Dosage: 1440 mg a day

Neoral
    Dosage: 100 mg, unk
    Administration route: Oral
    Start date: 2007-01-19
    End date: 2007-12-20

Neoral
    Dosage: 75 mg, unk
    Administration route: Oral
    End date: 2011-11-17

Neoral
    Dosage: 150 mg and 200 mg
    Administration route: Oral
    Indication: Immunosuppression
    Start date: 2000-12-15
    End date: 2007-01-18

Prednisone
    Dosage: 5 mg a day
    Administration route: Oral
    Start date: 2007-12-21

Prednisone
    Dosage: 7.5 mg a day
    Administration route: Oral
    Indication: Immunosuppression
    Start date: 2000-12-15
    End date: 2007-12-20

Other drugs received by patient: Steroids NOS; Simvastatin; Cellcept; Omeprazole; Iporel; Antihypertensive Drugs; Amlozek; Bisoprolol Fumarate; Polprazol



Possible Prednisone side effects in 21 year old female

Reported by a health professional (non-physician/pharmacist) from United States on 2012-07-26

Patient: 21 year old female

Reactions: Hyperbilirubinaemia, Nausea, Malnutrition, Hyperglycaemia, Abdominal Pain Upper, Hepatic Steatosis, Cholelithiasis, Fatigue, Hepatotoxicity, Cholangitis, Pancreatitis, Asthenia

Adverse event resulted in: hospitalization

Drug(s) suspected as cause:
Daunorubicin HCL
    Dosage: unspecified dosage modification
    Indication: Acute Lymphocytic Leukaemia

Pegaspargase
    Dosage: unspecified dosage modification
    Indication: Acute Lymphocytic Leukaemia

Prednisone
    Dosage: unspecified dosage modification
    Indication: Acute Lymphocytic Leukaemia

Vincristine
    Dosage: unspecified dosage modification
    Indication: Acute Lymphocytic Leukaemia



Possible Prednisone side effects in female

Reported by a physician from United States on 2012-07-26

Patient: female, weighing 50.6 kg (111.3 pounds)

Reactions: Nausea, Urinary Tract Infection, Cytomegalovirus Viraemia, Rhinorrhoea, Pyrexia, Renal Failure, Diarrhoea, Urosepsis, Neutropenia, Sinusitis

Adverse event resulted in: hospitalization

Drug(s) suspected as cause:
Bactrim
    Indication: Prophylaxis

Mycophenolate Mofetil
    Dosage: unk
    Administration route: Oral
    Start date: 2011-05-16
    End date: 2011-06-04

Mycophenolate Mofetil
    Dosage: 1000 mg, bid
    Administration route: Oral
    Indication: Renal Transplant
    Start date: 2010-08-24
    End date: 2011-05-16

Prednisone
    Dosage: 5 mg, qd
    Administration route: Oral
    Indication: Renal Transplant
    Start date: 2010-10-23

Prograf
    Dosage: 4 mg am, 5 mg pm
    Administration route: Oral
    Indication: Renal Transplant
    Start date: 2010-12-09
    End date: 2011-05-16

Prograf
    Dosage: 2 mg, bid
    Administration route: Oral
    Start date: 2011-05-16

Other drugs received by patient: Losartan Potassium; Lasix



Possible Prednisone side effects in female

Reported by a individual with unspecified qualification from United States on 2012-07-26

Patient: female

Reactions: Off Label Use, Nausea

Drug(s) suspected as cause:
Colcrys
    Administration route: Oral
    Indication: Behcet's Syndrome
    Start date: 2012-03-27

Prednisone
    Administration route: Oral
    Indication: Autoimmune Disorder
    Start date: 2012-04-02

Prednisone
    Administration route: Oral
    Start date: 2012-03-28
    End date: 2012-03-30

Prednisone
    Administration route: Oral
    Start date: 2012-03-31
    End date: 2012-04-01

Other drugs received by patient: Claritin (Childrens)



Possible Prednisone side effects in male

Reported by a physician from United States on 2012-07-25

Patient: male, weighing 89.7 kg (197.3 pounds)

Reactions: Dyspnoea, Syncope, Fatigue, Diarrhoea, Nausea, Wheezing, Hypoxia, Neutrophil Count Decreased

Adverse event resulted in: hospitalization

Drug(s) suspected as cause:
Amoxicillin
    Indication: Product Used FOR Unknown Indication

Avastin
    Dosage: over 30 - 90 minutes on day 1
    Indication: Prostate Cancer
    Start date: 2010-07-27

Docetaxel
    Dosage: over 60 minutes on day 1
    Indication: Prostate Cancer
    Start date: 2010-07-27

Lenalidomide
    Dosage: on day 1 - 14
    Administration route: Oral
    Indication: Prostate Cancer
    Start date: 2010-07-27

Prednisone
    Administration route: Oral
    Indication: Prostate Cancer
    Start date: 2010-07-27



Possible Prednisone side effects in 72 year old female

Reported by a physician from Canada on 2012-07-24

Patient: 72 year old female

Reactions: Abdominal Pain, Weight Decreased, Vomiting, Tinnitus, Nausea, Urinary Tract Infection, Bursitis, Wound Complication, Haemoglobin Decreased, Diarrhoea, Visual Impairment, Onychoclasis, Sleep Apnoea Syndrome, Asthenia, Inflammation

Adverse event resulted in: hospitalization

Drug(s) suspected as cause:
Arava

Cymbalta

Dilaudid

Lyrica
    Dosage: also taken 150mg

Orencia
    Dosage: last dose20oct11,15dec11,16dec11,7feb12,6mar12,13jul12 inf:11,57-500mg-also every 4 week,exp:ma2014
    Indication: Rheumatoid Arthritis
    Start date: 2011-08-01

Prednisone
    Dosage: also taken 15 mg

Other drugs received by patient: Nexium; Pramipexole Dihydrochloride; Amiloride Hydrochloride; Alendronate Sodium; Oxybutynin; Naproxen; Atenolol; Acetaminophen; Calcium; Calcitonin Salmon; Hydromorphone HCL



Possible Prednisone side effects in 21 year old female

Reported by a health professional (non-physician/pharmacist) from United States on 2012-07-24

Patient: 21 year old female

Reactions: Hyperbilirubinaemia, Fatigue, Nausea, Hyperglycaemia, Asthenia, Abdominal Pain Upper

Adverse event resulted in: hospitalization

Drug(s) suspected as cause:
PEG-Asparaginase
    Indication: Acute Lymphocytic Leukaemia

Prednisone
    Indication: Acute Lymphocytic Leukaemia

Other drugs received by patient: Vincristine; Daunorubicin HCL



Possible Prednisone side effects in female

Reported by a physician from United States on 2012-07-24

Patient: female, weighing 51.4 kg (113.1 pounds)

Reactions: Nausea, Urinary Tract Infection, Rhinorrhoea, Cytomegalovirus Viraemia, Pyrexia, Renal Failure, Diarrhoea, Urosepsis, Neutropenia, Sinusitis

Adverse event resulted in: hospitalization

Drug(s) suspected as cause:
Bactrim
    Indication: Prophylaxis

Mycophenolate Mofetil
    Dosage: 1000 mg, bid
    Administration route: Oral
    End date: 2011-05-16

Mycophenolate Mofetil
    Dosage: 1000 mg, bid
    Administration route: Oral
    Start date: 2011-05-16
    End date: 2011-06-04

Mycophenolate Mofetil
    Dosage: 1000 mg, bid
    Administration route: Oral
    Indication: Renal Transplant
    Start date: 2010-08-24
    End date: 2011-05-04

Prednisone
    Dosage: 5 mg, qd
    Administration route: Oral
    Indication: Renal Transplant
    Start date: 2010-10-23

Prograf
    Dosage: 4 mg am, 5 mg pm
    Administration route: Oral
    End date: 2011-05-16

Prograf
    Dosage: 2 mg, bid
    Administration route: Oral
    Start date: 2011-05-24

Prograf
    Dosage: 4 mg, bid
    Administration route: Oral
    Indication: Renal Transplant
    Start date: 2010-12-09

Prograf
    Dosage: unk
    Administration route: Oral
    Start date: 2011-05-16

Other drugs received by patient: Losartan Potassium; Lasix



Possible Prednisone side effects in female

Reported by a physician from Germany on 2012-07-24

Patient: female

Reactions: Vomiting, Nausea

Adverse event resulted in: hospitalization

Drug(s) suspected as cause:
Allopurinol
    Dosage: 150 mg, qd
    Start date: 2012-06-18

Cyclophosphamide
    Dosage: unk
    Indication: B-Cell Lymphoma
    Start date: 2012-07-04
    End date: 2012-07-04

Doxorubicin HCL
    Dosage: unk
    Indication: B-Cell Lymphoma
    Start date: 2012-07-04
    End date: 2012-07-04

Pegfilgrastim
    Dosage: unk
    Indication: B-Cell Lymphoma
    Start date: 2012-07-08
    End date: 2012-07-08

Prednisone
    Dosage: unk
    Indication: B-Cell Lymphoma
    Start date: 2012-07-04
    End date: 2012-07-04

Rituximab
    Dosage: unk
    Indication: B-Cell Lymphoma
    Start date: 2012-07-07
    End date: 2012-07-07

Vincristine
    Dosage: unk
    Indication: B-Cell Lymphoma
    Start date: 2012-07-04
    End date: 2012-07-04

Other drugs received by patient: Losartan Potassium; Bisoprolol Fumarate



Possible Prednisone side effects in

Reported by a consumer/non-health professional from United States on 2012-07-24

Patient:

Reactions: Product Quality Issue, Drug Ineffective, Nausea, Condition Aggravated

Drug(s) suspected as cause:
Prednisone



Possible Prednisone side effects in female

Reported by a consumer/non-health professional from United States on 2012-07-23

Patient: female, weighing 79.4 kg (174.6 pounds)

Reactions: Spinal Pain, Contusion, Nausea, Headache, Erythema, Somnolence, Fall, Gastric Disorder, Fatigue, Impaired Healing, Oedema Peripheral, Infusion Related Reaction

Drug(s) suspected as cause:
Prednisone
    Administration route: Oral
    Indication: Rheumatoid Arthritis
    End date: 2012-01-01

Prednisone
    Administration route: Oral
    Start date: 2012-01-01

Remicade
    Indication: Rheumatoid Arthritis
    Start date: 2012-05-25

Remicade
    Start date: 2012-01-01

Other drugs received by patient: Levothyroxine Sodium; Levothyroxine Sodium; Hydrochlorothiazide; Lutein; Aspirin; Omeprazole; Flonase; Lidoderm; Tramadol Hydrochloride; Lyrica; Cyclobenazprine; Albuterol Sulphate; Vitamin B Complex CAP; Hydrocodone; Flonase; Multi-Vitamins; Omega 3-6-9; Albuterol Sulphate



Possible Prednisone side effects in female

Reported by a physician from United States on 2012-07-20

Patient: female, weighing 55.0 kg (121.0 pounds)

Reactions: Hyperaesthesia, Diarrhoea, Nausea, Haemoglobin Abnormal, Immunosuppressant Drug Level Increased, Blood Creatinine Increased, Micturition Urgency

Adverse event resulted in: hospitalization

Drug(s) suspected as cause:
Mycophenolate Mofetil
    Dosage: 1000 mg, bid
    Administration route: Oral
    Indication: Renal Transplant
    Start date: 2011-10-19
    End date: 2011-12-15

Prednisone
    Dosage: 5 mg, cyclic
    Administration route: Oral
    Indication: Renal Transplant
    Start date: 2011-10-19
    End date: 2011-12-15

Rituximab
    Dosage: 314 mg, cyclic
    Indication: Renal Transplant
    Start date: 2011-10-20
    End date: 2011-10-20

Tacrolimus
    Dosage: 12 mg, cyclic
    Administration route: Oral
    Indication: Renal Transplant
    Start date: 2011-10-21
    End date: 2011-12-15

Thymoglobulin
    Dosage: 100 mg, cyclic
    Indication: Renal Transplant
    Start date: 2011-10-19
    End date: 2011-10-25

Velcade
    Dosage: 2 mg, cyclic
    Indication: Renal Transplant
    Start date: 2011-10-19
    End date: 2011-10-29

Other drugs received by patient: Nystatin; Albuterol; Colace; Bactrim; Coreg; Vitamin D; Synthroid; Topamax; Vitamin B-12; Miralax / 00754501 /; Percocet; Valcyte; Pepcid; Plaquenil



Possible Prednisone side effects in 53 year old male

Reported by a consumer/non-health professional from United States on 2012-07-18

Patient: 53 year old male, weighing 143.0 kg (314.6 pounds)

Reactions: Nausea, Visual Impairment, Feeling Abnormal, Asthenia, Nervousness

Drug(s) suspected as cause:
Prednisone
    Indication: Haematoma

Warfarin Sodium



Possible Prednisone side effects in 67 year old male

Reported by a health professional (non-physician/pharmacist) from Germany on 2012-07-12

Patient: 67 year old male, weighing 78.0 kg (171.6 pounds)

Reactions: Multi-Organ Failure, Spinal Pain, Nausea, Sepsis, Febrile Neutropenia, Dizziness, Hepatitis B, Cough

Adverse event resulted in: death, life threatening event, hospitalization, disablity

Drug(s) suspected as cause:
Melphalan Hydrochloride
    Dosage: .25 milligram/kilogram
    Indication: Multiple Myeloma
    Start date: 2009-01-29
    End date: 2009-02-02

Prednisone
    Dosage: 2 milligram
    Indication: Multiple Myeloma
    Start date: 2009-01-29
    End date: 2009-02-02

Thalidomide
    Dosage: 200 milligram
    Administration route: Oral
    Indication: Multiple Myeloma
    Start date: 2009-01-29
    End date: 2009-02-10

Other drugs received by patient: Kalium; Metamizol; Levothyroxine Sodium; Lactulose; Tramadol HCL; Nadroparin; Pantoprazole; Tamsulosin HCL; Allopurinol; Aspirin; Amphotericin B; Nadroparin



Possible Prednisone side effects in 83 year old male

Reported by a consumer/non-health professional from United States on 2012-07-09

Patient: 83 year old male, weighing 82.6 kg (181.6 pounds)

Reactions: White Blood Cell Count Decreased, Vomiting, Fatigue, Diarrhoea, Nausea, Pain, Muscle Spasms

Adverse event resulted in: hospitalization

Drug(s) suspected as cause:
Prednisone

Other drugs received by patient: Taxotere; ^too Many^ Unspecified Concomitant Medications



Possible Prednisone side effects in female

Reported by a consumer/non-health professional from United States on 2012-07-06

Patient: female, weighing 52.2 kg (114.8 pounds)

Reactions: Agitation, Contusion, Upper Limb Fracture, Coma, Chronic Obstructive Pulmonary Disease, Rheumatoid Arthritis, Malaise, Oedema Peripheral, Skin Atrophy, Ultrasound Kidney Abnormal, Vein Disorder, Cellulitis, Drug Withdrawal Syndrome, Convulsion, Anaemia of Chronic Disease, Enterococcus Test Positive, Fall, Skin Discolouration, Postoperative Wound Complication, Pleural Effusion, Gastrooesophageal Reflux Disease, Pathogen Resistance, Decreased Appetite, Renal Failure Acute, Fluid Overload, Nausea, Urinary Tract Infection, Condition Aggravated, Atrial Fibrillation, Nosocomial Infection, Heart Rate Increased, Sepsis, Hypothyroidism, Asthenia, Antibiotic Level Above Therapeutic

Adverse event resulted in: hospitalization

Drug(s) suspected as cause:
Prednisone
    Dosage: 5 mg;qd;po
    Administration route: Oral
    Indication: Rheumatoid Arthritis

Vancomycin
    Dosage: iv
    Indication: Cellulitis

Other drugs received by patient: Aspirin; Methocarbamol; Spiriva; Levothyroxine Sodium; Ondansetron; Forteo; Oxycontin; Diltiazem; Hydroxychloroquine Sulfate; Erythromycin; Advair Diskus 100 / 50



Possible Prednisone side effects in

Reported by a physician from United States on 2012-07-05

Patient:

Reactions: Fatigue, Central Nervous System Haemorrhage, Erythema Multiforme, Dyspnoea, Stomatitis, Vomiting, Gastrointestinal Toxicity, Nausea, Condition Aggravated, Rash, Haematotoxicity, Pulmonary Haemorrhage, Tumour Lysis Syndrome, Diarrhoea, Respiratory Failure, Neurological Symptom, Infection

Adverse event resulted in: death

Drug(s) suspected as cause:
Cyclophosphamide
    Dosage: for 5 days in cycle 1
    Indication: Burkitt's Lymphoma

Cyclophosphamide
    Dosage: days 1-5 during cycle 3,5 and 7

Cyclophosphamide
    Dosage: for 5 days in cycle 1
    Indication: Burkitt's Leukaemia

Cyclophosphamide
    Dosage: days 1-5 during cycle 3,5 and 7

Cytarabine
    Dosage: on days 4 and 5 of cycle 2,4 and 6
    Indication: Burkitt's Leukaemia

Cytarabine
    Dosage: on days 4 and 5 of cycle 2,4 and 6
    Indication: Burkitt's Lymphoma

Dexamethasone Sodium Phosphate
    Dosage: on days 1-5 of cycle 2,4 and 6

Dexamethasone Sodium Phosphate
    Dosage: on days 1-5 of cycle 2,4 and 6

Dexamethasone Sodium Phosphate
    Dosage: on days 1-5 of cycle 3,5 and 7
    Indication: Burkitt's Leukaemia

Dexamethasone Sodium Phosphate
    Dosage: on days 1-5 of cycle 3,5 and 7
    Indication: Burkitt's Lymphoma

Doxorubicin HCL
    Dosage: on days 4 and 5 of cycle 3,5 and 7
    Indication: Burkitt's Lymphoma

Doxorubicin HCL
    Dosage: on days 4 and 5 of cycle 3,5 and 7
    Indication: Burkitt's Leukaemia

Etoposide
    Dosage: on days 4 and 5 of cycle 2,4 and 6
    Indication: Burkitt's Lymphoma

Etoposide
    Dosage: on days 4 and 5 of cycle 2,4 and 6
    Indication: Burkitt's Leukaemia

Ifosfamide
    Dosage: on days 1-5 in cycle 2,4 and 6
    Indication: Burkitt's Lymphoma

Ifosfamide
    Dosage: on days 1-5 in cycle 2,4 and 6
    Indication: Burkitt's Leukaemia

Methotrexate
    Dosage: on day 1 of cycle 3,5 and 7
    Indication: Burkitt's Lymphoma

Methotrexate
    Dosage: on day 1 of cycle 2,4 and 6
    Indication: Burkitt's Leukaemia

Methotrexate
    Dosage: on day 1 of cycle 3,5 and 7

Methotrexate
    Dosage: on day 1 of cycle 2,4 and 6

Prednisone
    Dosage: for 7 days in cycle 1
    Indication: Burkitt's Lymphoma

Prednisone
    Dosage: for 7 days in cycle 1
    Indication: Burkitt's Leukaemia

Rituximab
    Dosage: on day 8 from cycle 3 to 7

Rituximab
    Dosage: on day 8 from cycle 3 to 7

Rituximab
    Dosage: day 8 on cycle 2; doage increased to 375 mg/m2 on day 10 and 12
    Indication: Burkitt's Leukaemia

Rituximab
    Dosage: day 8 on cycle 2; doage increased to 375 mg/m2 on day 10 and 12
    Indication: Burkitt's Lymphoma

Vincristine
    Dosage: on day 1 of cycle 3,5 and 7
    Indication: Burkitt's Lymphoma

Vincristine
    Dosage: on day 1 of cycle 2,4 and 6

Vincristine
    Dosage: on day 1 of cycle 3,5 and 7

Vincristine
    Dosage: on day 1 of cycle 2,4 and 6
    Indication: Burkitt's Leukaemia

Other drugs received by patient: Filgrastim; Unknown Medication; Leucovorin Calcium



Possible Prednisone side effects in

Reported by a physician from United States on 2012-07-05

Patient:

Reactions: Nausea, Anaemia, Chills, Constipation, Fatigue, Neuropathy Peripheral, Alopecia, Adverse Event, Neutropenia, Thrombocytopenia

Drug(s) suspected as cause:
Cyclophosphamide

Cyclophosphamide
    Indication: Chronic Lymphocytic Leukaemia

Cyclophosphamide
    Indication: B-Cell Lymphoma

Doxorubicin HCL
    Dosage: on day 1
    Indication: B-Cell Lymphoma

Doxorubicin HCL
    Dosage: on day 1

Doxorubicin HCL
    Dosage: on day 1
    Indication: Chronic Lymphocytic Leukaemia

Prednisone
    Dosage: on days 1-5
    Administration route: Oral
    Indication: B-Cell Lymphoma

Prednisone
    Dosage: on days 1-5
    Administration route: Oral
    Indication: Chronic Lymphocytic Leukaemia

Prednisone
    Dosage: on days 1-5
    Administration route: Oral

Rituximab
    Dosage: maintenance

Rituximab
    Dosage: on day 1
    Indication: B-Cell Lymphoma

Rituximab
    Dosage: maintenance

Rituximab
    Dosage: on day 1
    Indication: Chronic Lymphocytic Leukaemia

Rituximab
    Dosage: on day 1

Rituximab
    Dosage: maintenance

Velcade
    Dosage: on days 1 and 8

Velcade
    Dosage: on days 1 and 8
    Indication: Chronic Lymphocytic Leukaemia

Velcade
    Dosage: on days 1 and 8
    Indication: B-Cell Lymphoma



 Page 1   Next >>

-- advertisement -- The American Red Cross
 
Home | About Us | Contact Us | Site usage policy | Privacy policy

All Rights reserved - Copyright DrugLib.com, 2006-2017